Millions of Americans take antidepressants. And like all medication, they come with side effects. Researchers studied 30 ...

The DUO-O trial showed significant improvement in progression-free survival with Imfinzi, Avastin, and Lynparza, but no significant overall survival benefit. The study was a double-blind, multicenter ...

Aug. 13, 2004 — The U.S. Food and Drug Administration (FDA) and Genentech, Inc., sent a letter yesterday to healthcare professionals that warns of the risk for serious and fatal arterial ...

A new large-scale analysis found that the short-term cardiovascular and metabolic side effects of antidepressants vary widely ...

In patients with unresectable hepatocellular carcinoma (HCC), outcomes with atezolizumab plus bevacizumab are not improved by the addition of low-dose ipilimumab, according to research presented at ...